Keyphrases
Tolvaptan
100%
Renal Disease
100%
Early Treatment
100%
Prognostic Impact
100%
Acute Heart Failure
100%
Heart Failure Patients
37%
Combined Events
37%
All-cause Mortality
25%
Creatinine Ratio
25%
Combined Endpoints
25%
Acute Phase
12%
Readmission
12%
Subgroup Analysis
12%
Comorbidity
12%
Randomized Clinical Trial
12%
Hospitalization
12%
Prognostic Significance
12%
Event-free Survival
12%
No Significant Difference
12%
Survival Rate
12%
Conventional Treatment
12%
Preserved Renal Function
12%
Short-term Use
12%
Event Log
12%
Neutral Effects
12%
Pharmacology, Toxicology and Pharmaceutical Science
Tolvaptan
100%
Acute Heart Failure
100%
Creatinine
25%
Clinical Study
12%
Event Free Survival
12%
Survival Rate
12%
Comorbidity
12%
Biochemistry, Genetics and Molecular Biology
Tolvaptan
100%
Blood Urea Nitrogen
25%
Creatinine
25%
Clinical Study
12%
Event Free Survival
12%
Survival Rate
12%
Kidney Function
12%
Comorbidity
12%